[ad_1] — Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter — — Delivered $1.0 Million of Operating Income in Q3 2025 — SAN DIEGO, Nov. 13, 2025 /PRNewswire/ — Women’s […]

[ad_1] — Improved loss from operations by 31% — — Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health infections — — Forged commercial agreement for Phexxi in Middle East […]